Biocon Biologics collaborates with Yoshindo to commercialize bUstekinumab, bDenosumab in Japan
Denosumab, a biosimilar referencing Prolia, is a monoclonal antibody for the treatment of osteoporosis.
Source: medicaldialogues.in
Page 10 - Biocon Biologic News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Biocon Biologic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Biocon Biologic Today - Breaking & Trending Today
Latest News | Biocon Biologics Receives Observations from USFDA: Biocon
Get latest articles and stories on Latest News at LatestLY. Biocon Ltd on Wednesday said the US health regulator has issued Form 483s with 11 observations each for two sites in Bengaluru and six observations for a plant in Malaysia, following inspection of seven manufacturing facilities of its arm Biocon Biologics. Latest News | Biocon Biologics Receives Observations from USFDA: Biocon.
Source: latestly.com
Plaintiffs flee WDTX; Why Intel's NPE move makes sense; IP strategy at NuCurrent; Message from new IAM editor; Campinos' legacy challenge at the EPO; plus much more
Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days
Source: iam-media.com
The patent challenges of the Indian company set to become the world's biggest biosimilars business
In an exclusive interview Biocon Biologics’ chief IP counsel explains the issues that he and his team focus on – and how an upcoming, big-ticket merger will lead to change
Source: iam-media.com
Biocon Biologics Malaysian arm enters Malaysia Book of Records
Biocon Biologics has created a Center of Excellence (CoE) for insulins in Malaysia with end-to-end capabilities to manufacture a broad portfolio of regular, basal and rapid insulins.
Source: medicaldialogues.in